Dow Jones Declines as Nike Stock Hits Oversold Territory
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 04 2026
0mins
Should l Buy UHS?
Source: CNBC
- Nike Oversold Status: Nike's relative strength index (RSI) has plummeted to 15.8 after a 14% drop in share price over the past week, indicating investor impatience with the company's turnaround, as it forecasts a 2% to 4% decline in fourth-quarter sales, below the 1.9% growth expected by analysts.
- Market Reaction: The Dow Jones Industrial Average fell as President Trump warned that the Iran war could last for weeks, coupled with surging oil prices, which pushed stocks in real estate, consumer staples, healthcare, and technology sectors into oversold territory, positioning them for a potential rebound in the near term.
- Analyst Downgrades: Several firms downgraded Nike's stock, citing that the new forecast indicates a longer-than-expected turnaround time, particularly due to the impacts of Middle Eastern disruptions and rising oil prices, which could further hinder sales growth.
- McCormick Acquisition Plans: McCormick & Company announced plans to acquire Unilever's global foods business for approximately $45 billion, reflecting a trend toward consolidation in the food industry, although the mixed historical performance of such megadeals raises questions about future market success.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy UHS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on UHS
Wall Street analysts forecast UHS stock price to rise
15 Analyst Rating
7 Buy
7 Hold
1 Sell
Moderate Buy
Current: 174.350
Low
190.00
Averages
248.00
High
302.00
Current: 174.350
Low
190.00
Averages
248.00
High
302.00
About UHS
Universal Health Services, Inc. is a holding company. The Company operates, through its subsidiaries, including its management company. It is engaged in owning and operating acute care hospitals and outpatient facilities, and behavioral healthcare facilities. Its segments include acute care hospital services, behavioral health care services, and Other. It owns and operates approximately 359 inpatient facilities, and 60 outpatient and other facilities located in 39 states, Washington, D.C., the United Kingdom, and Puerto Rico. It provides services, which include general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services and/or behavioral health services. It also provides capital resources, as well as a variety of management services to its facilities, including information services, finance and control systems, physician recruitment services, and public relations.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Earnings Announcement: Universal Health Services (UHS) is set to release its Q1 2023 earnings report on April 27 after market close, with a consensus EPS estimate of $5.46, reflecting a 12.8% year-over-year increase, indicating ongoing improvement in profitability.
- Revenue Growth Expectations: The anticipated revenue for Q1 is $4.39 billion, representing a 7.1% year-over-year increase, which highlights the company's stable growth in the healthcare sector and rising market demand, potentially boosting investor confidence.
- Historical Performance: Over the past two years, UHS has beaten EPS estimates 88% of the time and revenue estimates 75% of the time, a strong performance record that may attract more investor interest and enhance its market valuation.
- Estimate Revision Dynamics: In the last three months, EPS estimates have seen 5 upward revisions and 4 downward revisions, while revenue estimates have experienced 6 upward and 4 downward revisions, indicating analysts' confidence in UHS's future performance and adjustments in market expectations.
See More
- Strong Market Performance: The S&P 500 and Nasdaq Composite indices reached new all-time highs in April, rising over 8% and 13% respectively, indicating robust market resilience despite ongoing geopolitical tensions and AI disruption concerns, reflecting investor confidence in tech stocks.
- Earnings Pressure on Tech Giants: Next week, five of the 'Magnificent Seven' companies will report earnings, with market expectations for them to demonstrate sufficient revenue growth to justify their high AI expenditures; Alphabet, Amazon, Meta, and Microsoft have all seen stock price increases of over 10% this month, highlighting the market's keen interest in their performance.
- Federal Reserve Meeting Impact: This is expected to be Jerome Powell's last meeting as chair, with the market widely anticipating that the Fed will keep interest rates unchanged, although rising oil prices could complicate future monetary policy, necessitating close attention to how this dynamic may affect the market.
- Cautious Investor Sentiment: As the traditional market adage 'Sell in May' approaches, investors remain wary of potential downside risks, particularly in light of poor software stock performance and rising oil prices, which could further dampen market sentiment.
See More
- Market Decline: The S&P 500 Index fell by 0.90%, the Dow Jones Industrial Average dropped by 0.76%, and the Nasdaq 100 Index decreased by 1.40%, reflecting investor concerns over geopolitical tensions, particularly the potential escalation of conflict between Iran and the US.
- Oil Price Surge: Crude oil prices rose over 3% to a four-week high as the market watches for Iran's response to a ceasefire deadline tonight, with failure to reach an agreement potentially leading to broader military conflict and impacting global energy supplies.
- Positive Economic Data: Despite the overall market downturn, February's non-defense capital goods new orders increased by 0.6% month-over-month, surpassing expectations of 0.5%, indicating resilience in US capital spending that could support future market stability.
- Bond Market Reaction: The 10-year Treasury note yield rose to 4.357% as rising oil prices boosted inflation expectations, while the market's diminished outlook for a Fed rate hike reflects investor caution regarding future economic policies.
See More
- Earnings Release Schedule: Universal Health Services will report its Q1 2026 earnings after market close on April 27, 2026, providing investors with the latest financial performance and operational data to analyze company trends.
- Investor Conference Call: A conference call for investors and analysts is scheduled for April 28, 2026, at 9:00 a.m. Eastern Time, aimed at providing in-depth insights into the earnings report and addressing investor inquiries to enhance transparency and communication.
- Live Webcast Availability: The conference call will be available via live webcast on the company's website, ensuring that global investors can access real-time information, thereby increasing the company's visibility and engagement among investors.
- Telephone Participation Registration: Participants must register in advance to receive dial-in information and a unique passcode, ensuring a smooth meeting process and enhancing the participant experience, reflecting the company's commitment to investor relations.
See More
- Nike Oversold Status: Nike's relative strength index (RSI) has plummeted to 15.8 after a 14% drop in share price over the past week, indicating investor impatience with the company's turnaround, as it forecasts a 2% to 4% decline in fourth-quarter sales, below the 1.9% growth expected by analysts.
- Market Reaction: The Dow Jones Industrial Average fell as President Trump warned that the Iran war could last for weeks, coupled with surging oil prices, which pushed stocks in real estate, consumer staples, healthcare, and technology sectors into oversold territory, positioning them for a potential rebound in the near term.
- Analyst Downgrades: Several firms downgraded Nike's stock, citing that the new forecast indicates a longer-than-expected turnaround time, particularly due to the impacts of Middle Eastern disruptions and rising oil prices, which could further hinder sales growth.
- McCormick Acquisition Plans: McCormick & Company announced plans to acquire Unilever's global foods business for approximately $45 billion, reflecting a trend toward consolidation in the food industry, although the mixed historical performance of such megadeals raises questions about future market success.
See More

- Merger and Acquisition Activity: The year has seen significant merger and acquisition activity, with many deals nearing closure.
- Stock Performance: Stocks of companies being acquired are expected to rise upon the completion of these deals.
See More










